260 related articles for article (PubMed ID: 17900104)
1. Proteomic identification of the cerebral cavernous malformation signaling complex.
Hilder TL; Malone MH; Bencharit S; Colicelli J; Haystead TA; Johnson GL; Wu CC
J Proteome Res; 2007 Nov; 6(11):4343-55. PubMed ID: 17900104
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
[TBL] [Abstract][Full Text] [Related]
3. Cerebral cavernous malformation proteins at a glance.
Draheim KM; Fisher OS; Boggon TJ; Calderwood DA
J Cell Sci; 2014 Feb; 127(Pt 4):701-7. PubMed ID: 24481819
[TBL] [Abstract][Full Text] [Related]
4. Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate.
Dibble CF; Horst JA; Malone MH; Park K; Temple B; Cheeseman H; Barbaro JR; Johnson GL; Bencharit S
PLoS One; 2010 Jul; 5(7):e11740. PubMed ID: 20668527
[TBL] [Abstract][Full Text] [Related]
5. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.
Tang AT; Sullivan KR; Hong CC; Goddard LM; Mahadevan A; Ren A; Pardo H; Peiper A; Griffin E; Tanes C; Mattei LM; Yang J; Li L; Mericko-Ishizuka P; Shen L; Hobson N; Girard R; Lightle R; Moore T; Shenkar R; Polster SP; Rödel CJ; Li N; Zhu Q; Whitehead KJ; Zheng X; Akers A; Morrison L; Kim H; Bittinger K; Lengner CJ; Schwaninger M; Velcich A; Augenlicht L; Abdelilah-Seyfried S; Min W; Marchuk DA; Awad IA; Kahn ML
Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776290
[TBL] [Abstract][Full Text] [Related]
6. Notch Signaling in Familial Cerebral Cavernous Malformations and Immunohistochemical Detection of Cleaved Notch1 Intracellular Domain.
Hasan SS; Fischer A
Methods Mol Biol; 2020; 2152():427-435. PubMed ID: 32524570
[TBL] [Abstract][Full Text] [Related]
7. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.
Zawistowski JS; Stalheim L; Uhlik MT; Abell AN; Ancrile BB; Johnson GL; Marchuk DA
Hum Mol Genet; 2005 Sep; 14(17):2521-31. PubMed ID: 16037064
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
[TBL] [Abstract][Full Text] [Related]
9. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
10. Hyperosmotic induction of mitogen-activated protein kinase scaffolding.
Hilder TL; Malone MH; Johnson GL
Methods Enzymol; 2007; 428():297-312. PubMed ID: 17875425
[TBL] [Abstract][Full Text] [Related]
11. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
12. STRIPAK complexes: structure, biological function, and involvement in human diseases.
Hwang J; Pallas DC
Int J Biochem Cell Biol; 2014 Feb; 47():118-48. PubMed ID: 24333164
[TBL] [Abstract][Full Text] [Related]
13. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
[TBL] [Abstract][Full Text] [Related]
14. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.
Fisher OS; Boggon TJ
Cell Mol Life Sci; 2014 May; 71(10):1881-92. PubMed ID: 24287896
[TBL] [Abstract][Full Text] [Related]
15. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
[TBL] [Abstract][Full Text] [Related]
16. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
17. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
18. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
19. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.
Voss K; Stahl S; Schleider E; Ullrich S; Nickel J; Mueller TD; Felbor U
Neurogenetics; 2007 Nov; 8(4):249-56. PubMed ID: 17657516
[TBL] [Abstract][Full Text] [Related]
20. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
Pagenstecher A; Stahl S; Sure U; Felbor U
Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
